Abivax S.A. Cash And Cash Equivalents
Abivax S.A. (ABVX) had Cash And Cash Equivalents of EUR 516.68 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-23
- 2025-12-31: Cash And Cash Equivalents 516.68M EUR.
- 2025-09-30: Cash And Cash Equivalents 589.70M EUR.
- 2025-06-30: Cash And Cash Equivalents 60.95M EUR.
- 2025-03-31: Cash And Cash Equivalents 103.58M EUR.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | 516.68M EUR 20-F · filed 2026-03-23 |
| 2025-09-30 | 589.70M EUR 6-K · filed 2025-12-15 |
| 2025-06-30 | 60.95M EUR 6-K · filed 2025-09-08 |
| 2025-03-31 | 103.58M EUR 6-K · filed 2025-06-02 |
| 2024-12-31 | 144.22M EUR 20-F · filed 2026-03-23 |
| 2024-09-30 | 180.45M EUR 6-K · filed 2025-12-15 |
| 2024-06-30 | 222.32M EUR 6-K · filed 2025-09-08 |
| 2024-03-31 | 241.61M EUR 6-K · filed 2025-06-02 |
| 2023-12-31 | 251.94M EUR 20-F · filed 2026-03-23 |
| 2022-12-31 | 26.95M EUR 20-F · filed 2026-03-23 |
| 2021-12-31 | 60.70M EUR 20-F · filed 2025-03-24 |
| 2020-12-31 | 29.30M EUR 20-F · filed 2024-04-05 |